Medicine and Dentistry
Antiplatelet
28%
Apoplexy
14%
Atrial Fibrillation
100%
Blood Stasis
14%
Combination Therapy
28%
Coronary Artery Disease
28%
Coronary Stenting
100%
Major Bleeding
14%
Monotherapy
100%
Myocardial Infarction
14%
Revascularization
14%
Rivaroxaban
100%
Stenting
57%
Subgroup Analysis
14%
Thrombosis
14%
Unstable Angina Pectoris
14%
Pharmacology, Toxicology and Pharmaceutical Science
Antiplatelet
28%
Atrial Fibrillation
100%
Bleeding
14%
Blood Stasis
14%
Combination Therapy
28%
Coronary Artery Disease
28%
Heart Infarction
14%
Monotherapy
100%
Rivaroxaban
100%
Thrombosis
14%
Unstable Angina Pectoris
14%
Keyphrases
Clinical Time
14%
Therapy Cessation
14%